Naylor
Pharma
ARC Document?Solutions
Australia
Biography
Gordon Naylor was appointed President of Seqirus, CSL's global influenza business, in 2015. Prior to his current role Gordon was Chief Financial Officer for parent company CSL Limited.
Research Interest
Life science
